{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:34:05Z","timestamp":1789155245667,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-026-02034-x","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:31:44Z","timestamp":1780983104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paraneoplastic Cerebellar Degeneration Due to Tonsillar Cancer; A Case Series"],"prefix":"10.1007","volume":"25","author":[{"given":"Joshua M.","family":"Simmons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Jefferis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Sionis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J. A.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Hadjivassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"16","key":"2034_CR1","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMra023009","volume":"349","author":"RB Darnell","year":"2003","unstructured":"Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349(16):1543\u201354. https:\/\/doi.org\/10.1056\/NEJMra023009.","journal-title":"N Engl J Med"},{"issue":"3","key":"2034_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11910-023-01250-w","volume":"23","author":"M Gilligan","year":"2023","unstructured":"Gilligan M, McGuigan C, McKeon A. Paraneoplastic neurologic disorders. Curr Neurol Neurosci Rep. 2023;23(3):67\u201382. https:\/\/doi.org\/10.1007\/s11910-023-01250-w.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"11","key":"2034_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11912-018-0721-y","volume":"20","author":"RS Grativvol","year":"2018","unstructured":"Grativvol RS, Cavalcante WCP, Castro LHM, Nitrini R, Simabukuro MM. Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes. Curr Oncol Rep. 2018;20(11):92. https:\/\/doi.org\/10.1007\/s11912-018-0721-y.","journal-title":"Curr Oncol Rep"},{"issue":"Suppl 2","key":"2034_CR4","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.4103\/aian.aian_102_22","volume":"25","author":"SJ Hickman","year":"2022","unstructured":"Hickman SJ. Paraneoplastic syndromes in neuro-ophthalmology. Ann Indian Acad Neurol. 2022;25(Suppl 2):S101\u20135. https:\/\/doi.org\/10.4103\/aian.aian_102_22.","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"2034_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/0964704X.2015.1021120","volume":"24","author":"P Schulz","year":"2015","unstructured":"Schulz P. \u201cHirnsymptome bei Carcinomatose\u201d - Hermann Oppenheim and an early description of a paraneoplastic neurological syndrome. J Hist Neurosci. 2015;24(4):371\u20137. https:\/\/doi.org\/10.1080\/0964704X.2015.1021120.","journal-title":"J Hist Neurosci"},{"issue":"3","key":"2034_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/brain\/88.3.529","volume":"88","author":"PC Wilkinson","year":"1965","unstructured":"Wilkinson PC. Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy. Brain. 1965;88(3):529\u201338. https:\/\/doi.org\/10.1093\/brain\/88.3.529.","journal-title":"Brain"},{"issue":"6","key":"2034_CR7","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1007\/s10072-022-06083-y","volume":"43","author":"VH Ganaraja","year":"2022","unstructured":"Ganaraja VH, Rezk M. Paraneoplastic neurological syndrome: growing spectrum and relevance. Neurol Sci. 2022;43(6):3583\u201394. https:\/\/doi.org\/10.1007\/s10072-022-06083-y.","journal-title":"Neurol Sci"},{"issue":"3","key":"2034_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/antib12030050","volume":"12","author":"D Chiu","year":"2023","unstructured":"Chiu D, Rhee J, Gonzalez Castro LN. Diagnosis and treatment of paraneoplastic neurologic syndromes. Antibodies (Basel). 2023;12(3):50. https:\/\/doi.org\/10.3390\/antib12030050.","journal-title":"Antibodies (Basel)"},{"issue":"5","key":"2034_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s1548-5315(11)70395-3","volume":"7","author":"J Dalmau","year":"2010","unstructured":"Dalmau J, Rosenfeld MR. Update on paraneoplastic neurologic disorders. Community Oncol. 2010;7(5):219\u201324. https:\/\/doi.org\/10.1016\/s1548-5315(11)70395-3.","journal-title":"Community Oncol"},{"issue":"7","key":"2034_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","volume":"13","author":"CA Vedeler","year":"2006","unstructured":"Vedeler CA, Antoine JC, Giometto B, Graus F, Grisold W, Hart IK, et al. Management of paraneoplastic neurological syndromes: report of an EFNS task force. Eur J Neurol. 2006;13(7):682\u201390. https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01266.x.","journal-title":"Eur J Neurol"},{"issue":"1","key":"2034_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14802\/jmd.20040","volume":"14","author":"H Mitoma","year":"2021","unstructured":"Mitoma H, Manto M, Hadjivassiliou M. Immune-mediated cerebellar ataxias: clinical diagnosis and treatment based on immunological and physiological mechanisms. J Mov Disord. 2021;14(1):10\u201328. https:\/\/doi.org\/10.14802\/jmd.20040.","journal-title":"J Mov Disord"},{"issue":"1\u20132","key":"2034_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jns.2014.01.004","volume":"338","author":"C Kamiya-Matsuoka","year":"2014","unstructured":"Kamiya-Matsuoka C, Blas-Boria D, Williams MD, Garciarena P, Tummala S, Tremont-Lukats I-. N-type calcium channel antibody-mediated paraneoplastic limbic encephalitis: a diagnostic challenge. J Neurol Sci. 2014;338(1\u20132):188\u201390. https:\/\/doi.org\/10.1016\/j.jns.2014.01.004.","journal-title":"J Neurol Sci"},{"key":"2034_CR13","unstructured":"Janus JR, Chinnadurai S, Moore EJ. Case report: Paraneoplastic neurologic syndrome associated with squamous cell carcinoma of the tonsil. Ear Nose Throat J 2013 Oct-Nov;92(10\u201311):E13. PMID: 24170469."},{"issue":"1","key":"2034_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s42399-022-01256-4","volume":"174","author":"V Lorah","year":"2022","unstructured":"Lorah V, Ferreira A, Janda P, et al. A case of paraneoplastic Lambert Eaton myasthenic syndrome associated with tonsillar carcinoma. SN Compr Clin Med. 2022;174:174. https:\/\/doi.org\/10.1007\/s42399-022-01256-4.","journal-title":"SN Compr Clin Med"},{"issue":"1","key":"2034_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1471-2377-13-147","volume":"13","author":"C Henke","year":"2013","unstructured":"Henke C, et al. Paraneoplastic cerebellar degeneration associated with lymphoepithelial carcinoma of the tonsil. BMC Neurol. 2013;13(1):147\u2013147. https:\/\/doi.org\/10.1186\/1471-2377-13-147.","journal-title":"BMC Neurol"},{"issue":"1","key":"2034_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/aian.AIAN_975_20","volume":"24","author":"A Vijayaraghavan","year":"2021","unstructured":"Vijayaraghavan A, Alexander PT, Nair AV, Sivadasan A, Mani AM, Mathew D, et al. Clinical spectrum, therapeutic outcomes and prognostic predictors in paraneoplastic neurological syndromes - experiences from a tertiary care center in India. Ann Indian Acad Neurol. 2021;24(1):32\u20139. https:\/\/doi.org\/10.4103\/aian.AIAN_975_20.","journal-title":"Ann Indian Acad Neurol"},{"key":"2034_CR17","doi-asserted-by":"publisher","unstructured":"Shah S, et al. Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes. Neurology: Neuroimmunol neuroinflammation. 2022;9(2). https:\/\/doi.org\/10.1212\/NXI.0000000000001124.","DOI":"10.1212\/NXI.0000000000001124"},{"issue":"1","key":"2034_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00415-019-09544-1","volume":"267","author":"A Vogrig","year":"2020","unstructured":"Vogrig A, et al. Epidemiology of paraneoplastic neurological syndromes: a population-based study. J Neurol. 2020;267(1):26\u201335. https:\/\/doi.org\/10.1007\/s00415-019-09544-1.","journal-title":"J Neurol"},{"key":"2034_CR19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1600-0404.2008.01089.x","volume":"119","author":"M Hadjivassiliou","year":"2009","unstructured":"Hadjivassiliou M, Alder SJ, Van Beek EJR, Hannay MB, Lorenz E, Rao DG, Sharrack B, Tindale WB. PET scan in clinically suspected paraneoplastic neurological syndromes: A six year prospective study in a regional neuroscience unit. Acta Neurol Scand. 2009;119:186\u201393.","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"2034_CR20","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001014","volume":"8","author":"F Graus","year":"2021","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, Antoine JG, Desestret V, Dubey D, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e1014. https:\/\/doi.org\/10.1212\/NXI.0000000000001014.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"2034_CR21","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2169\/internalmedicine.43.602","volume":"43","author":"J Konishi","year":"2004","unstructured":"Konishi J, et al. Paraneoplastic cerebellar degeneration (PCD) associated with squamous cell carcinoma of the lung. Intern Med. 2004;43(7):602\u20136. https:\/\/doi.org\/10.2169\/internalmedicine.43.602.","journal-title":"Intern Med"},{"issue":"4","key":"2034_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.clineuro.2005.01.008","volume":"108","author":"K Bruylant","year":"2006","unstructured":"Bruylant K, Crols R, Humbel RL, Appel B, De Deyn PP. Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung. Clin Neurol Neurosurg. 2006;108(4):415\u20137. https:\/\/doi.org\/10.1016\/j.clineuro.2005.01.008.","journal-title":"Clin Neurol Neurosurg"},{"key":"2034_CR23","doi-asserted-by":"publisher","unstructured":"Zhu Y, et al. An uncommon manifestation of paraneoplastic cerebellar degeneration in a patient with high grade urothelial, carcinoma with squamous differentiation: a case report and literature review. BMC Cancer. 2016;16(1):324\u2013324, 324. https:\/\/doi.org\/10.1186\/s12885-016-2349-3.","DOI":"10.1186\/s12885-016-2349-3"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02034-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-026-02034-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02034-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:09:52Z","timestamp":1786165792000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-026-02034-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2034"],"URL":"https:\/\/doi.org\/10.1007\/s12311-026-02034-x","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"90"}}